Dihydroartemisinin-induced inhibition of proliferation in BEL-7402 cells: An analysis of the mitochondrial proteome

Molecular Medicine Reports

Volumn 6, Issue 2, 2012, Pages 429-433

  Lu, Jin Jian ^a,b   Yang, Zhen ^a   Lu, De Zhao ^a   Wo, Xing De ^a   Shi, Jia Jie ^a   Lin, Tao Qi ^a   Wang, Mi Mi ^a   Li, Yi ^a   Tang, Li Hua ^a  

^a ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^b University of Macau   (Macao)

Author keywords

Dihydroartemisinin; Energy metabolism; Hepatocarcinoma; Mitochondria; Proteomics

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; ARTEMISININ; DIHYDROARTEMISININ; ENOYL COENZYME A HYDRATASE; FERREDOXIN NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE REDUCTASE; FUMARATE HYDRATASE; HEAT SHOCK PROTEIN 60; MITOCHONDRIAL PROTEIN; PROTEOME; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CATALYSIS; CELL PROLIFERATION; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENERGY METABOLISM; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OXIDATION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

3-HYDROXYACYL COA DEHYDROGENASES; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ARTEMISIA ANNUA; ARTEMISININS; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENERGY METABOLISM; ENOYL-COA HYDRATASE; FUMARATE HYDRATASE; HUMANS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

ARTEMISIA ANNUA;

EID: 84863499265     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.906     Document Type: Article

References (26)

1. White NJ: Qinghaosu (artemisinin): the price of success. Science 320: 330-334, 2008.
2. Lu JJ, Meng LH, Cai YJ, et al: Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent of iron and p38 mitogen-activated protein kinase activation but independent of reactive oxygen species. Cancer Biol Ther 7: 1017-1023, 2008.
3. Efferth T, Sauerbrey A, Olbrich A, et al: Molecular modes of action of artesunate in tumor cell lines. Mol Pharmacol 64: 382-394, 2003. (Pubitemid 36910002)
4. Efferth T, Olbrich A and Bauer R: mRNA expression profiles for the response of human tumor cell lines to the antimalarial drugs artesunate, arteether, and artemether. Biochem Pharmacol 64: 617-623, 2002.
5. Li LN, Zhang HD, Yuan SJ, Tian ZY, Wang L and Sun ZX: Artesunate attenuates the growth of human colorectal carcinoma and inhibits hyperactive Wnt/beta-catenin pathway. Int J Cancer 121: 1360-1365, 2007. (Pubitemid 47293806)
6. Jiao Y, Ge CM, Meng QH, Cao JP, Tong J and Fan SJ: Dihydroartemisinin is an inhibitor of ovarian cancer cell growth. Acta Pharmacol Sin 28: 1045-1056, 2007. (Pubitemid 47020494)
7. Chen T, Li M, Zhang R and Wang H: Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy. J Cell Mol Med 13: 1358-1370, 2009.
8. Tan W, Lu J, Huang M, et al: Anti-cancer natural products isolated from chinese medicinal herbs. Chin Med 6: 27, 2011.
9. Mercer AE, Maggs JL, Sun XM, et al: Evidence for the involvement of carbon-centered radicals in the induction of apoptotic cell death by artemisinin compounds. J Biol Chem 282: 9372-9382, 2007. (Pubitemid 47104599)
10. Efferth T, Benakis A, Romero MR, et al: Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron. Free Radic Biol Med 37: 998-1009, 2004. (Pubitemid 39164582)
11. Efferth T: Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells. Curr Drug Targets 7: 407-421, 2006.
12. Singh NP and Lai H: Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells. Life Sci 70: 49-56, 2001. (Pubitemid 33130042)
13. Lu JJ, Chen SM, Zhang XW, Ding J and Meng LH: The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells. Invest New Drugs 29: 1276-1283, 2011.
14. Lu YY, Chen TS, Qu JL, Pan WL, Sun L and Wei XB: Dihydroartemisinin (DHA) induces caspase-3-dependent apoptosis in human lung adenocarcinoma ASTC-a-1 cells. J Biomed Sci 16: 16, 2009.
15. Chen H, Sun B, Pan S, Jiang H and Sun X: Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo. Anticancer Drugs 20: 131-140, 2009.
16. Lu JJ, Meng LH, Shankavaram UT, et al: Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells. Biochem Pharmacol 80: 22-30, 2010.
17. Du JH, Zhang HD, Ma ZJ and Ji KM: Artesunate induces oncosis-like cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo. Cancer Chemother Pharmacol 65: 895-902, 2010.
18. Li W, Mo W, Shen D, et al: Yeast model uncovers dual roles of mitochondria in action of artemisinin. PLoS Genet 1: e36, 2005.
19. Reungpatthanaphong P and Mankhetkorn S: Modulation of multidrug resistance by artemisinin, artesunate and dihydroartemisinin in K562/adr and GLC4/adr resistant cell lines. Biol Pharm Bull 25: 1555-1561, 2002. (Pubitemid 39663669)
20. Lu JJ, Chen SM, Ding J and Meng LH: Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line. Mol Cell Biochem 360: 329-337, 2012.
21. King A, Selak MA and Gottlieb E: Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. Oncogene 25: 4675-4682, 2006. (Pubitemid 44187617)
22. Li Z, Zhao X, Yang J and Wei Y: Proteomics profile changes in cisplatin-treated human ovarian cancer cell strain. Sci China C Life Sci 48: 648-657, 2005. (Pubitemid 44843832)
23. Castagna A, Antonioli P, Astner H, et al: A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431. Proteomics 4: 3246-3267, 2004. (Pubitemid 39372405)
24. Lai MY, Hour MJ, Wing-Cheung Leung H, Yang WH and Lee HZ: Chaperones are the target in aloe-emodin-induced human lung nonsmall carcinoma H460 cell apoptosis. Eur J Pharmacol 573: 1-10, 2007. (Pubitemid 47495905)
25. Chen ST, Pan TL, Tsai YC and Huang CM: Proteomics reveals protein profile changes in doxorubicin--treated MCF-7 human breast cancer cells. Cancer Lett 181: 95-107, 2002.
26. Cappello F, Conway de Macario E, Marasa L, Zummo G and Macario AJ: Hsp60 expression, new locations, functions and perspectives for cancer diagnosis and therapy. Cancer Biol Ther 7: 801-809, 2008.